Skip to main content

Table 2 Relationship between tumor syndecan-1 status and patient 5 year and median survival

From: Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: An immunohistochemical study of clinically annotated tumors

Syndecan-1

Scoring

5 yr survival

rate (%)

Median

survival

(months)

95% CI

0

38.6

43

21–97

1+

47.7

49

16–82

2+

52.0

83

45–121

3+

43.7

57

5–109